Rajesh J. Asorpota
EVP & Chief Financial OfficerMr. Rajesh J. Asorpota, also known as Raj, serves as an Independent Director of Profusa, Inc. since July 11, 2025. He is Executive Vice President and Chief Financial Officer of Maravai LifeSciences Holdings, Inc. since June 30, 2025 and June 22, 2025, respectively. He served as Chief Financial Officer and Executive Vice President at Augmedics LTD from September 15, 2021 until August 2025, leading the global finance organization and overseeing accounting, treasury, financial planning and analysis, tax and investor relations. He served as Chief Financial Officer at ApiJect Systems, Corp. from September 2020 to October 2021. He served as Executive Vice President and Chief Financial Officer of NuVasive, Inc. from September 1, 2017 until September 2020 and as Chief Financial Officer and Senior Vice President of Questcor Pharmaceuticals, Inc. from February 17, 2014, which was acquired by Mallinckrodt in 2014. He also served as Principal Accounting Officer at Questcor. He joined Questcor from Life Technologies Corporation, where he held various global financial leadership roles, including Vice President of Finance, responsible for growth strategy, supply chain productivity, forecasting, analysis and financial modeling for mergers and acquisitions. During his tenure, Life Technologies’ revenue grew from approximately 1B to more than 4B in 2014, leading to its sale to Thermo Fisher for 13.6 billion. Prior to Life Technologies, he spent 11 years at General Electric Corporation (GE), holding various financial positions including roles in commercial operations, plant and manufacturing analysis, sourcing and R&D analysis, beginning with the GE Financial Management program. He also spent two years in private equity at Imaging Advantage and Cole Parmer as Executive Vice President and Chief Financial Officer; Imaging Advantage was acquired by Envision in 2015. He holds an M.B.A. from Marquette University and a Bachelor of Commerce from the University of Bombay.
Positions
- Company NameMaravai LifeSciences Holdings, Inc.Stock CodeMRVIPositionEVP & Chief Financial OfficerColleagues
- RARobert Andrew EckertChairman of the Board
- BBBernd BrustCEO & Director
- KAKurt A. OreshackExecutive VP, General Counsel & Secretary
- CDChristine DolanExecutive VP & GM of Cygnus Technologies
- SGSusannah GrayIndependent Director
- JAJohn A. DeFordIndependent Director
- GTGregory Thomas LucierIndependent Director
- Company NameProfusa, Inc.Stock CodeNVACWPositionIndependent DirectorRelated SecuritiesColleagues
- CHChung-Bin HwangPresident
- JEJack E. StoverCEO & Executive Chairman
- FSFred S. KnechtelChief Financial Officer
- WMWilliam McMillanCo-founder, Chief Scientific Officer & Head of Research
- DIDavid IckeHead of Digital Health Business
- HCHaeyong ChungIndependent Director
- RJRajesh J. AsorpotaIndependent Director
- PMPeter M. O’RourkeLead Independent Director
- LGLiviu GoldenbergIndependent Director
